<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>r10q-415.txt
<DESCRIPTION>CERTIFICATION OF CFO
<TEXT>
EXHIBIT 32.2



             CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                 AS ADOPTED PURSUANT TO SECTION 906 OF
                    THE SARBANES-OXLEY ACT OF 2002


The certification set forth below is hereby made solely for the purpose
of satisfying the requirements of Section 906 of the Sarbanes-Oxley Act
of 2002 and may not be relied upon or used for any other purposes.

In connection with the Quarterly Report of Access Pharmaceuticals, Inc.
(the "Company") on Form 10-Q for the period ended June 30, 2003, as
filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Stephen B. Thompson, Chief Financial Officer certify
pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes Oxley Act of 2002, that to my knowledge (1) the Report fully
complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and (2) the information contained in the Report
fairly presents, in all material respects, the financial condition and results
of operations of the Company.

A signed original of this written statement required by Section 906 or
other document authenticating, acknowledging or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906 has been provided to the
Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.

Signed at the City of  Dallas, in the State of Texas, this 14th day of
August, 2003.


/s/ Stephen B. Thompson
-----------------------
Stephen B. Thompson

Chief Financial Officer




</TEXT>
</DOCUMENT>
